Conclusions
Malignant pleural effusion, a common complication of advanced malignancy, is associated with significant morbidity and mortality. The symptoms of MPE (dyspnea, cough, pleuritic pain) can be debilitating and can result in prolonged hospitalization at a considerable cost. Several therapeutic regimens have been designed to improve such patients’ quality of life by palliating these symptoms. Although controversy still exists as to which therapy is optimal for individual patients, a critical review of the existing management options allows patients and physicians to have open discussions on the utility of the currently available treatment strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Sahn SA. Malignancy metastatic to the pleura. Clin Chest Med 1998;19:351–361.
Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5255 samples from 3811 patients. Diagn Cytopathol 1987;3:8.
Belani CP, Pajeau TS, Bennett CL. Treating malignant pleural effusions cost consciously. Chest 1998;113:78S–85S.
Tattersall M. Management of malignant pleural effusion. Aust NZ J Med 1998;28:394–396.
Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977;63:695.
Maher GG, Berger HW. Massive pleural effusion: malignant and non-malignant causes in 46 patients. Am Rev Respir Dis 1972;105:458.
Fiocco M, Krasna MJ. The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am 1997;11:253–265.
Fraser RS, Colman N, Müller NL, Paré PD. Pleural effusion. In: Diagnosis of Diseases of the Chest, 4 th ed. Philadelphia: Saunders, 1999;2739–2778.
Winkelmann M, Pfitzer P. Blind pleural biopsy in combination with cytology of pleural effusions. Acta Cytol 1981;25:373–376.
Weisberg D, Daufman M. Diagnostic and therapeutic pleuroscopy: experience with 127 patients. Chest 1980;78:732.
Fraser RS, Coleman N, Müller NL, Paré PD. The pleura. In: Synopsis of Diseases of the Chest, 2 nd ed. Philadelphia: Saunders, 1994;868–895.
Colice GL, Rubins JB. Practical management of pleural effusions: when and how should fluid accumulations be drained? Postgrad Med 1999;105:67–77.
Belani CP, Ziskind AA, Dhawan M, Lemmon CC. Management of malignant pleural and pericardial effusions. In: Aisner J, Green, Perry, Arriagada, Martini (eds). Comprehensive Textbook of Thoracic Oncology. Baltimore: Williams & Wilkins, 1996;880–905.
Rosso R, Rimoldi R, Salvati F, et al. Intrapleural natural beta interferon in the treatment of malignant pleural effusion. Oncology 1998;45:253–256.
Yasumoto K, Ogura T. Intrapleural application of recombinant interleukin-2 patients with malignant pleurisy due to lung cancer: a multi-institutional cooperative study. Biotherapy 1991;3:345–349.
Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A. Management of malignant pleural effusions. Drugs 1998;55:47–58.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Barresi, R.V., Millikan, K.W. (2003). Malignant Pleural Effusion. In: Saclarides, T.J., Millikan, K.W., Godellas, C.V. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/0-387-21701-0_75
Download citation
DOI: https://doi.org/10.1007/0-387-21701-0_75
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95201-7
Online ISBN: 978-0-387-21701-7
eBook Packages: Springer Book Archive